Identification of an apoptotic cleavage product of BARD1 as an autoantigen: A potential factor in the antitumoral response mediated by apoptotic bodies

Cancer Research

Volumn 60, Issue 24, 2000, Pages 6895-6900

  Gautier, Fabien ^a   Irminger Finger, Irmgard ^b   Grȳgoire, Marc ^a   Meflah, Khaled ^a   Harb, Jean ^a  

^a INSTITUT DE BIOLOGIE   (France)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BARD1 ANTIGEN; BRCA1 PROTEIN; CALPAIN; CALPASTATIN; CASPASE INHIBITOR; CYSTEINE PROTEINASE; EGTAZIC ACID; METHIONINE; SULFUR 35; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CARCINOMA CELL; CARCINOMATOSIS; CELL CYCLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMORAL IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RAT; SEQUENCE ANALYSIS; TUMOR IMMUNITY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; AUTOANTIGENS; BLOTTING, WESTERN; BRCA1 PROTEIN; BREAST NEOPLASMS; CALPAIN; CARRIER PROTEINS; CELL CYCLE; CELL FRACTIONATION; CLONING, MOLECULAR; COLONIC NEOPLASMS; CYSTEINE PROTEINASE INHIBITORS; DNA, COMPLEMENTARY; EGTAZIC ACID; ENZYME INHIBITORS; GENE LIBRARY; HUMANS; LEUPEPTINS; MAMMARY NEOPLASMS, ANIMAL; MICE; MOLECULAR SEQUENCE DATA; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 0034671305     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cancer statistics
2. Accomplishments in surgical adjuvant therapy for large bowel cancer
3. Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial
4. Vaccination of melanoma patients with peptide- or tumor lysatepulsed dendritic cells
5. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
6. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
7. An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis
8. Butyrate modulates DNA-damage-induced p53 response by induction p53-independent differentiation and apoptosis
9. The inability to process a self-peptide allows autoreactive T cells to escape tolerance
10. DNA-dependent kinase is one of a subset of autoantigens specifically cleaved early during apoptosis
11. Systemic exposure to irradiated apoptotic cells induces autoantibody production
12. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease
13. Apoptosis induced by sodium butyrate treatment increases immunogenicity of a rat colon tumor cell line
14. Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines
15. Identification of a RING protein that can interact in vivo with the BRCA1 gene product
16. Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to syngeneic host
17. Mutation in the BRCA1-associated RING domain (BARD1) gene in primary breast ovarian and uterine cancers
18. Production and characterization of a monoclonal antibody specific for apoptotic bodies derived from several tumor cell lines
19. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains
20. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
21. In vitro repression of BRCA1-associated RING domain gene, BARD1, induces phenotypic changes in mammary epithelial cells
22. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin
23. Purification and characterization of a protein inhibitor of calcium-dependent protease from rat liver
24. + T lymphocytes
25. Inducing autoimmune disease to treat cancer
26. Capture and processing of exogenous antigens for presentation on MHC molecules
27. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization
28. Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin
29. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein
30. Who binds wins: Competition for PCNA rings out cell cycle changes
31. Association of BRCA1 with Rad51 in mitotic and meiotic cells
32. Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein
33. A human RNA polymerase II complex associated with SRB and DNA-repair proteins
34. BRCA1 required for transcription-coupled repair of oxidative DNA damage
35. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor cstF-50
36. Mapping the functional domains of BRCA1: Interaction of the RING finger domains of BRCA1 and BARD1
37. Activation of multiple interleukin-Iβ converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis
38. Demonstration of three calpains in the matrix of rat liver mitochondria
39. Substrate specificities of caspase family proteases
40. Calpain, an upstream regulator of thymocyte apoptosis
41. Bax cleavage is mediated by calpain during drug-induced apoptosis